Dr. Armin Schwarzbach, MD, PhD is a MD and a specialist for laboratory medicine from the laboratory ArminLabs, Augsburg, Germany.
Dr. Schwarzbach developed the worldwide first Radioimmunoassay (RIA) for human Gastric Inhibitory Polypeptide (hGIP) from 1986 – 1991, getting his PhD in 1992. Dr. Schwarzbach worked as a medical assistant at Limburg hospital in internal medicine, oncology, cardiology, gastroenterology, nephrology, and infectiology for several years. By 1993 Dr. Schwarzbach started specializing in laboratory medicine in infectiology, microbiology, immunology, hematology, clinical chemistry, endocrinology and gynecological endocrinology.
Dr. Schwarzbach was appointed in March 2013 as the International Expert for the Chief Medical Officer´s Clinical Advisory Committee on Lyme Disease in Australia (CACLD) of the Australian Government, Department of Health and Ageing, Canberra, Australia. In November 2013
Dr. Schwarzbach was appointed as the European expert for Lyme disease in Ireland by the Irish Parliament, Joint Committee on Health and Children, Dublin, Ireland. He was member of the working groups for Lyme disease of the Haut Conseil de la Sante Publique, Paris, France, and the Complex Chronic Diseases Program BC Women's Hospital and Health Centre, Vancouver, B.C., Canada. Dr. Schwarzbach took part as a key-speaker at the Lyme Disease Parliamentary Meeting, House of Commons, 19th January 2015 in London, England.
Dr. Schwarzbach currently works at his new and autonomous laboratory ArminLabs in Augsburg, Germany (www.arminlabs.com)